An observational study in Financial Impact of Stem Cell Transplantation, sponsored by Center for International Blood and Marrow Transplant Research. Completed at 3 sites in United States. Per ClinicalTrials.gov, last updated 2015-10-06.
Sponsored by Center for International Blood and Marrow Transplant Research · Observational
The purpose of this pilot study is to determine the feasibility of conducting a study of out-of-pocket costs and the long-term financial impact of allogeneic stem cell transplant.
Allogeneic hematopoietic stem cell transplantation (HSCT) is the indicated treatment for many life-threatening illnesses affecting both adults and children. Transplant recovery and late effects require long-term medical care. At the same time that the family faces a medical crisis, a resulting financial crisis may also be pending, but is often pushed to the background due to the necessity of first preserving life. A large proportion of patients undergoing HSCT incur significant financial burden from out-of-pocket costs and a decrease in household income. Predetermined variables, both medical and demographic, gathered at the pre-transplant clinical consultation have the potential to predict the patients at greatest financial risk. This study will describe both the out-of-pocket costs and the income changes that may result from HSCT to help patients and their caregivers have a clearer picture of these costs and develop a financial plan. Health care providers can utilize this information to better inform patients and connect them to resources.
Center for International Blood and Marrow Transplant Research is the lead sponsor of 30 studies on the registry; 7 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Pediatric and adult allogeneic stem cell transplant recipients and their care givers from three U.S. transplant medical centers.
Exclusion Criteria:
Pediatric and adult allogeneic stem cell transplant recipients and their care givers.
Other: Household financial data collection
Baseline financial survey pre-transplant, financial diary post-transplant every two weeks for 3 months, and financial questionnaire via phone survey at 6, 12, 18 and 24 months post-transplant.
To study the feasibility of using a patient maintained diary to capture out-of-pocket costs over the first 3 months following allogeneic HSCT
Time frame: Pre-transplant and for 3 months post-transplant
To determine the feasibility of conducting interviews to collect financial information at 6, 12, 18 and 24 months after allogeneic HSCT
Time frame: 6, 12, 18 and 24 month time points post-transplant
This study is completed, as verified in Oct 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Center for International Blood and Marrow Transplant Research